Skip to main content
SecondaryClaims
Back to Condition Library

Glioblastoma PACT Act Presumptive

How veterans claim glioblastoma and other brain cancers as PACT Act presumptive conditions from toxic exposure. Covers eligibility, 100% rating, evidence, and critical filing guidance.

Last updated: 2026-04-18

What Is Glioblastoma as a PACT Act Presumptive?

Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor — a Grade IV malignancy of the glial cells of the brain. It carries a devastatingly poor prognosis: median survival from diagnosis is approximately 12–18 months even with aggressive treatment including surgery, radiation, and chemotherapy (Stupp protocol). Veterans diagnosed with glioblastoma after qualifying service under the PACT Act are entitled to presumptive service connection — and to the immediate, full benefits that service connection provides.

The PACT Act's recognition of glioblastoma and other malignant brain tumors as presumptive conditions acknowledges the documented association between certain toxic exposures in military environments — including radiofrequency radiation, organic solvents, and heavy metals — and brain cancer development. More broadly, the legislation recognizes that veterans who served in burn pit environments were exposed to complex mixtures of carcinogens whose individual risks are difficult to quantify but whose aggregate exposure burden is substantial.

For veterans with glioblastoma and their families: file immediately. Given the severity of this diagnosis and the limited time available, every week of delay in establishing service connection is a week of benefits not received. VA-accredited VSOs can help expedite the claims process for terminal diagnoses.

Why the VA Recognizes This Connection

Ionizing and non-ionizing radiation exposure. Veterans with military occupations involving radar systems, communications equipment, and electronic countermeasures have elevated radiofrequency and microwave radiation exposures. Research suggests associations between prolonged RF radiation exposure and brain tumor risk, forming part of the biological plausibility for the presumptive.

Organosolvents and hematological/neurological carcinogens. Military environments involve extensive exposure to benzene, trichloroethylene, and other organic solvents with documented carcinogenic properties. These compounds have been implicated in central nervous system tumor development.

Burn pit combustion products. The complex organic chemistry of burn pit combustion produces dioxins, polycyclic aromatic hydrocarbons, and other compounds that are carcinogenic through multiple mechanisms including DNA adduct formation and immunosuppression.

Pesticide and herbicide exposures. Veterans serving in Southwest Asia were exposed to significant pesticide applications (malathion, DEET, permethrin) that have been studied for their effects on CNS carcinogenesis.

The VA's toxic exposure and cancer presumptives page provides information on the full presumptive list.

Evidence That Wins This Claim

For the presumptive pathway:

  • Proof of qualifying service: DD-214 documenting active duty service in covered locations on or after August 2, 1990.
  • Glioblastoma diagnosis: Pathology report confirming WHO Grade IV glioma/glioblastoma multiforme. MRI with gadolinium enhancement and surgical biopsy/resection pathology are the standard diagnostic confirmation.
  • Neurosurgery and oncology records: Treatment records documenting diagnosis, staging, and treatment plan.

Urgency documentation:

  • Terminal prognosis statement: A physician's opinion about prognosis (terminal within 6 months) may qualify for expedited processing through the VA's VSSC (Veterans Service Speed Center) or terminal illness protocols.

How the VA Rates Glioblastoma

Active malignancies are rated under 38 CFR § 4.29 and § 4.30:

StatusRating
Active treatment100% automatic from the date of diagnosis
Post-treatment, sustained remissionRe-evaluated under residuals criteria at 6-month follow-up
Recurring or treatment-resistantMaintained at 100%

Given glioblastoma's typical course, the 100% rating is likely to be sustained indefinitely. Post-treatment ratings are based on neurological residuals — cognitive impairment, motor weakness, seizures — which are themselves ratable.

Why These Claims Get Denied — And How to Prevent It

Filing delayed. For terminal diagnoses, delay directly reduces benefits received. File immediately after diagnosis using all available expedited processing options.

Qualifying service not documented. Ensure DD-214 and service records clearly show qualifying deployment. Seek help from a VSO to pull service records if needed.

Pathology report not included. The cancer diagnosis must be confirmed by pathology. Ensure the pathology report is included with the initial claim.

Survivors not aware of DIC eligibility. If a veteran dies before or during the claims process, their surviving spouse and dependents may be eligible for DIC and other survivor benefits. Family members should contact a VSO immediately after a veteran's death.

PACT Act presumptive theory not used. Some veterans or their families file under general direct service connection theories when the PACT Act presumptive is available — which requires no nexus letter and is faster to establish.

Related Conditions

Next Steps

File immediately. For terminal diagnoses, the VA's terminal illness expedited processing is available. Contact a VA-accredited VSO for same-day filing assistance. The PACT Act Claims Playbook provides step-by-step guidance.


This is educational content, not legal advice. SecondaryClaims.com is not accredited by the VA under 38 CFR § 14.629. For accredited representation, consult a VA-accredited VSO, claims agent, or attorney at https://www.va.gov/ogc/apps/accreditation/.